Adbiotech Co (XKRX:179530) Accounts Payable & Accrued Expense : ₩949 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Adbiotech Co Accounts Payable & Accrued Expense?

Adbiotech Co's quarterly accounts payable & accrued expense declined from Sep. 2023 (₩938 Mil) to Dec. 2023 (₩649 Mil) but then increased from Dec. 2023 (₩649 Mil) to Mar. 2024 (₩949 Mil).

Adbiotech Co's annual accounts payable & accrued expense declined from Dec. 2021 (₩1,721 Mil) to Dec. 2022 (₩905 Mil) and declined from Dec. 2022 (₩905 Mil) to Dec. 2023 (₩649 Mil).

Adbiotech Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Adbiotech Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adbiotech Co Accounts Payable & Accrued Expense Chart

Adbiotech Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

1,057.95

1,373.44

1,720.83

904.65

649.37

Adbiotech Co Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial									1,255.88	886.49	938.36	649.37	949.46

Adbiotech Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Adbiotech Co (XKRX:179530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adbiotech Co Ltd (XKRX:179530) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

39, Geodudanji 1-gil, Dongnae-myeon, Gangwon-do, Chuncheon, KOR, 24398

Website

http://www.adbiotech.com

Adbiotech Co Ltd is a life science company. It develops a vaccine and antibiotic-friendly substances such as IgY, Immunoglobulin in Yolk for human, animal and fish oral antibody products, and functional cosmetics and food additives. The company aim to develop Helico IgY, Cholesterol IgY, and Ulcerative Colitis natural product medicines.

Adbiotech Co (XKRX:179530) Headlines

No Headlines